EVOKE PHARMA, INC. Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-04-10: Form ARS; Period of report 2024-12-31; Description ARS; Document ars_4.10.25.pdf.
- 2024-05-14: Form ARS/A; Period of report 2023-12-31; Description ARS/A; Document evoke-_arsa_restate.pdf.
- 2024-04-10: Form ARS; Period of report 2023-12-31; Description ARS; Document evoke-_ars_4.10.24.pdf.
- 2023-03-29: Form ARS; Period of report 2022-12-31; Description ARS; Document evok-10k-31dec2022-ars.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-04-10 | ARS | 2024-12-31 | ARS | ars_4.10.25.pdf |
| 2024-05-14 | ARS/A | 2023-12-31 | ARS/A | evoke-_arsa_restate.pdf |
| 2024-04-10 | ARS | 2023-12-31 | ARS | evoke-_ars_4.10.24.pdf |
| 2023-03-29 | ARS | 2022-12-31 | ARS | evok-10k-31dec2022-ars.pdf |